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Background: Oxidative stress and inflammation may contribute to the disruption of the protective gut barrier through 
various mechanisms; mitochondrial dysfunction resulting from inflammatory and oxidative injury may potentially be a 
significant source of apoptosis during necrotizing enterocolitis (NEC). Tumor necrosis factor (TNF)α is thought to gener-
ate reactive oxygen species (ROS) and activate the apoptosis signal-regulating kinase 1 (ASK1)-c-Jun N-terminal kinase 
(JNK)/p38 pathway. Hence, the focus of our study was to examine the effects of TNFα/ROs on mitochondrial function, 
ASK1-JNK/p38 cascade activation in intestinal epithelial cells during NEC.
Results: We found (a) abundant tissue TNFα and ASK1 expression throughout all layers of the intestine in neonates 
with NEC, suggesting that TNFα/ASK1 may be a potential source (indicators) of intestinal injury in neonates with NEC; 
(b) TNFα-induced rapid and transient activation of JNK/p38 apoptotic signaling in all cell lines suggests that this may be an 
important molecular characteristic of NEC; (c) TNFα-induced rapid and transient ROs production in RIe-1 cells indicates 
that mitochondria are the predominant source of ROS, demonstrated by significantly attenuated response in mitochon-
drial DNA-depleted (RIE-1-ρ°) intestinal epithelial cells; (d) further studies with mitochondria-targeted antioxidant PBN 
supported our hypothesis that effective mitochondrial ROS trapping is protective against TNFα/ROs-induced intestinal 
epithelial cell injury; (e) TNFα induces significant mitochondrial dysfunction in intestinal epithelial cells, resulting in in-
creased production of mtROS, drop in mitochondrial membrane potential (MMP) and decreased oxygen consumption; 
(f) although the significance of mitochondrial autophagy in NEC has not been unequivocally shown, our studies provide a 
strong preliminary indication that TNFα/ROs-induced mitochondrial autophagy may play a role in NeC, and this process 
is a late phenomenon.
Methods: Paraffin-embedded intestinal sections from neonates with NEC and non-inflammatory condition of the gas-
trointestinal tract undergoing bowel resections were analyzed for TNFα and ASK1 expression. Rat (RIE-1) and mitochon-
drial DNA-depleted (RIE-1-ρ°) intestinal epithelial cells were used to determine the effects of TNFα on mitochondrial 
function.
Conclusions: Our findings suggest that TNFα induces significant mitochondrial dysfunction and activation of mito-
chondrial apoptotic responses, leading to intestinal epithelial cell apoptosis during NeC. Therapies directed against mito-
chondria/ROs may provide important therapeutic options, as well as ameliorate intestinal epithelial cell apoptosis during 
NeC.
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Results
Increased expression of TNFα and ASK1 in intestinal sections 
from human NEC and ASK1 expression in vitro. Examination 
of intestinal sections from NEC showed typical denuded intesti-
nal mucosal structure (Fig. 1A; top row) when compared to con-
trols from a non-inflammatory condition (intestinal atresia) of 
the gut. In intestinal sections from NEC, we observed abundant 
tissue TNFα expression throughout all layers of the intestine (Fig. 
1A; middle row). Given these findings, we next determined the 
expression of ASK1 during NEC. Correlative to TNFα, ASK1 
levels were also increased throughout all layers of the intestinal 
sections from NEC (Fig. 1A; bottom row). These increased lev-
els of intestinal TNFα and ASK1 during NEC can be potential 
markers of intestinal injury in neonates with NEC.
To  examine  the  effects  of  TNFα  on  pool  level  of  ASK1, 
TNFα-treated RIE-1 cells were analyzed using confocal micros-
copy and Zeiss LSM 5 image software. We found marked increase 
in ASK1 expression (pseudo-purple) in both the cytosol and at 
cell membranes at 15 minutes (min) when compared to control 
cells (Fig. 1B). These findings suggest an overall pool increase 
in ASK1 cellular levels, and in particular, increased ASK1 accu-
mulation at cell membranes consistent with ASK1 recruitment 
to activated TNFα and death receptors. More in-depth studies 
of TNFα-induced ASK1 accumulation at the cell membrane in 
RIE-1 cells are warranted. Western blotting also demonstrated 
early increase in total pool levels of ASK1 after TNFα treatment 
(Fig. 1C) in intestinal epithelial cells. Future studies targeting 
TNFα-induced  fluctuations  in  mitochondrial  versus  cytoso-
lic activated ASK1 protein expression levels in RIE-1 cells, and 
mitochondrial Trx(SH)2-ASK1 complex dissociation specifically, 
are necessary.
TNFα-induced  mtROS,  MMPΔ,  autophagy  and  O2  con-
sumption alterations in vitro and autophagic vacuolization in 
vivo. To determine the effects of TNFα/ROS on mitochondrial 
function in intestinal epithelial cells, we first examined whether 
mitochondria are the predominant source of intracellular ROS in 
RIE-1 cells similar to other cell types described by various inves-
tigators.13 We also examined the effects of TNFα/ROS on mito-
chondrial membrane potential (MMP) and oxygen consumption 
by  RIE-1  cells.  RIE-1  and  mitochondrial  DNA  (mtDNA)-
depleted RIE-1-ρ° cells were used to determine ROS levels.
A significant and rapid rise in intracellular ROS levels was noted 
at 15 and 30 min after TNFα treatment (ratio of stimulated vs. 
baseline ROS levels, r > 1) in parental RIE-1 cells, whereas RIE-
1-ρ° cells did not respond to TNFα stimulation, and the baseline 
ROS levels remained relatively unchanged (Fig. 2A). These find-
ings demonstrate that mitochondria are the predominant source 
of  TNFα-induced  intracellular  ROS  production  in  intestinal 
epithelial cells and concur with other cell type findings, where 
this effect is observed to be very rapid and transient. Effects of 
TNFα on MMPΔ in RIE-1 cells were also rapid and transient in 
nature, demonstrating peak levels of altered MMP within 15 and 
30 min after TNFα treatment and recovery of MMP observed at 
60 min (Fig. 2B). This finding suggests a significant susceptibil-
ity of mitochondria to TNFα injury demonstrated by a rapid and 
Introduction
Necrotizing enterocolitis (NEC) is the most common gastroin-
testinal surgical emergency in premature low birth-weight neo-
nates, where prematurity is the single most important risk factor. 
Although several contributing factors for NEC have been identi-
fied, such as ischemia, bacteria, cytokines and enteral feeding, 
the exact mechanisms for its pathogenesis remain elusive. The 
clinical presentation of NEC is often nonspecific and unpredict-
able. NEC frequently involves diffuse areas of bowel necrosis and 
perforation,  necessitating  emergency  operation.  The  presence 
of pneumatosis intestinalis detected on plain abdominal radio-
graphs  remains  as  a  pathognomonic  clinical  feature.  Despite 
extensive research during the past two decades, the exact patho-
genesis of NEC for premature neonates remains ill-defined and 
largely unknown, hence, limiting development of novel preven-
tive strategies.
Reactive oxygen species (ROS), generated as a result of isch-
emia-reperfusion injury to the gut, have been linked to the devel-
opment of NEC in premature infants.1,2 However, cytokines are 
also thought to play a role in ROS generation, contributing to 
severe  gut  inflammation  and  injury  during  NEC  hallmarked 
by  the  exaggerated  inflammatory  responses  by  the  premature 
immune system.3,4
Tumor necrosis factor (TNF)α, a pro-inflammatory cytokine 
implicated in various inflammatory diseases of the small intes-
tine,5,6  is  thought  to  contribute  to  the  pathogenesis  of  NEC. 
Recent  in  vivo  NEC  studies  have  demonstrated  a  significant 
decrease in the severity and incidence of intestinal injury with 
anti-TNFα therapy.7,8 TNFα-induced oxidative stress via mito-
chondrial ROS (mtROS) generation has recently emerged as a 
new mechanism of inducing cellular injury. Several studies have 
shown that mtROS generated by TNFα can oxidize the reduced 
thioredoxin-apoptosis  signal-regulating  kinase  1  (Trx(SH)2-
ASK1) complex,9-13 thus initiating its dissociation and inducing 
activation of ASK1 and its downstream stress signaling targets 
such as c-Jun N-terminal kinase (JNK) and p38 mitogen-acti-
vated protein kinase (MAPK) pathways.14-16
ASK1 is a member of the MAPK family, and is an upstream 
activator of JNK and p38-MAPK signaling cascades.17 ASK1 can 
be activated in response to TNFα/ROS and triggers various bio-
logical responses such as apoptosis, inflammation, differentiation 
and survival in various cell types.13,18-22 TNFα/mtROS-induced 
Trx oxidation results in the dissociation of the Trx(SH)2-ASK1 
complex, release of ASK1 and activation of p38 MAPK and JNK 
stress response pathways.16,23-26 Thus, ASK1 is important in the 
regulation of ROS and inflammation-induced apoptotic signal-
ing in injured cells;16,27,28 however, its role in intestinal epithelial 
cells during oxidative injury is unknown.
Oxidative stress and inflammation may contribute to the dis-
ruption of the protective gut barrier through various mechanisms; 
however, mitochondrial dysfunction resulting from inflammatory 
and oxidative injury may potentially be a significant source of apop-
tosis during NEC. Hence, the focus of our study was to examine 
the effects of TNFα/ROS on mitochondrial function, and ASK1-
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evaluate mouse intestinal sections for evidence of 
autophagy. Initially, we treated RIE-1 cells with 
TNFα for various time points (15, 30, 60, 90 min 
and 24 hours), and labeled cells with organelle-
specific  dyes,  MitoTracker  (mitochondria,  red 
fluorescence)  and  LysoTracker  (lysosomes,  green 
fluorescence).  Laser  scanning  confocal  micros-
copy  did  not  reveal  significant  mitochondrial 
autophagy at early time points (data not shown); 
however, when cells were treated with TNFα for 
24 hours (h), and then labeled, we found signifi-
cant  co-localization  of  damaged  mitochondria 
with lysosomes (yellow fluorescence) and typical 
morphologic changes (Fig. 2D) consistent with 
mitochondrial  damage  and  autophagy  of  dys-
functional mitochondria. These findings suggest 
that TNFα-induced mitochondrial autophagy is a late phenom-
enon in contrast to more rapid and transient mitochondrial ROS 
production, MMPΔ, reduction in cellular respiration, activation 
of  mitochondrial  apoptotic  signaling  pathways  and  JNK/p38 
stress pathways. Late autophagy may represent cellular inability 
to cope with overwhelming burden of damaged mitochondria. 
When taken together with RIE-1 cell death ELISA results (Fig. 
3A) after TNFα treatment, these data suggest that mitochon-
drial autophagy may play a pro-apoptotic role during cytokine-
induced injury in intestinal epithelial cells.
Cross-sectional views of mouse NEC intestinal villi showed 
ubiquitous autophagic vacuolization in intestinal epithelial cells 
in contrast with healthy controls (Fig. 2E). The degree of vacu-
olization is significant and may represent an adaptive function 
in stressed intestinal epithelial cells in vivo. Histological evalua-
tion and electron scanning microscopy of human NEC sections 
would be helpful in examining autophagic vacuolization in intes-
tinal epithelial cells.
TNFα-induced  RIE-1  cell  apoptosis  is  mitochondria-
dependent.  Next,  we  sought  to  examine  whether  TNFα 
induces apoptosis in intestinal epithelial cells. We treated RIE-1 
and RIE-1-ρ° cells with TNFα and DNA fragmentation was 
quantitated. TNFα-induced RIE-1 cell death was significantly 
transient drop in MMP, increased permeability and “leakiness” 
of the mitochondrial membrane which could result in the release 
of an apoptosis-activating molecule such as cytochrome c into 
the cytosol. MMP depolarization is an important early indicator 
of apoptotic signaling activation, and hence, transient and rapid 
MMPΔ  in  response  to  cytokine-induced  injury  demonstrates 
mitochondrial susceptibility in RIE-1 cells.
The oxygen consumption level in TNFα-treated RIE-1 cells 
was measured using a Clark-type electrode. TNFα treatment 
induced a significant decrease in oxygen consumption level of 
RIE-1 cells within the first minute of treatment with relatively 
depressed levels; this effect persisted for 5 min after TNFα treat-
ment (Fig. 2C). This finding demonstrates that mitochondrial 
functional changes occur rather rapidly in response to TNFα, and 
that the mitochondrial oxygen consumption is rapidly decreased 
within the first minute of TNFα exposure. Taken together, these 
results demonstrate that TNFα induces significant mitochondrial 
dysfunction in intestinal epithelial cells, resulting in functional 
derangements such as increased production of mtROS, signifi-
cant alteration in MMP and decreased oxygen consumption.
Organelle  autophagy  occurs  as  a  result  of  cellular  injury. 
Hence,  we  next  examined  the  effects  of  TNFα  treatment 
on  mitochondrial  autophagy  in  RIE-1  cells  and  sought  to 
Figure 1. Increased TNFα and ASK1 expres-
sion during NEC. (A) The intestinal sections from 
neonates with NEC and non-inflammatory condi-
tion (intestinal atresia; control) were assessed for 
TNFα and ASK1 expression. Representative section 
demonstrates villous tip blunting and inflammatory 
cell infiltration in NEC sections (top). Increased levels 
of TNFα (middle) and ASK1 (bottom) were localized 
to mucosa, submucosa and muscular layers in NeC 
(brown staining). (B) RIE-1 cells (1 x 104/well) were 
treated with TNFα (10 ng/mL) for 15 min, incubated 
with anti-ASK1 antibody, AlexaFluor® 647-labeled 
goat anti-rabbit IgG (pseudo purple) and Hoechst 
33342 nuclear stain (blue), and were visualized using 
confocal microscopy. TNFα treatment resulted in 
rapid increase in intracellular ASK1 expression in 
RIE-1 cells. (C) TNFα treatment also increased ASK1 
expression in RIE-1 cells by western blotting. Equal 
β-actin levels and densitometry indicate even loading.300  Oxidative Medicine and Cellular Longevity  Volume 2 Issue 5
western blot analysis. The expression of mitochondrial apoptotic 
markers (apoptosis-inducing factor (AIF), APAF-1, cytochrome 
c) and ATP synthase-β, a marker for the activity of the electron 
transport chain, were increased in RIE-1 cells after TNFα treat-
ment (Fig. 3C). This effect peaked at 15 min and returned to 
basal levels by 60 min. In contrast, the mtDNA-depleted RIE-
1-ρ° cells displayed no significant alteration in expression lev-
els of mitochondrial apoptotic markers, with the exception of a 
minimal increase in cytochrome c release at 15 min. This find-
ing may represent either delayed protein degradation or altered 
nuclear encoding of mitochondrial proteins and enzymes that is 
unaffected by mtDNA silencing.
decreased in TNFα-treated RIE-1-ρ° cells (Fig. 3A). These data 
imply that TNFα-exerted cellular injury mechanism(s) is pre-
dominantly mitochondria-dependent in RIE-1 cells.
When  baseline  levels  of  mitochondrial  apoptotic  markers 
such  as  Apoptotic  protease  activating  factor  1  (APAF-1)  and 
cytochrome c in RIE-1 and RIE-1-ρ° cells are compared, the 
mitochondrial expression of these apoptotic molecules is signifi-
cantly reduced in mtDNA-silenced RIE-1-ρ° cell line (Fig. 3B). 
Hence, the effect of cytokine-induced injury may be dependent 
or independent of mitochondrial apoptotic arsenal. To test this 
hypothesis,  we  examined  the  effects  of  TNFα  on  mitochon-
drial apoptotic pathway activation in intestinal epithelial cells by 
Figure 2. TNFα induces mitochondrial functional deregulation in intestinal epithelial cells. (A) RIE-1 and RIE-1-ρ° cells (1 x 106) were treated with 
TNFα, incubated with DCFH-DA for 15 min for ROS level. In RIE-1 cells, TNFα treatment induced rapid, transient rise in intracellular ROs. The ratio 
of stimulated vs. baseline ROS levels increased (r > 1) in TNFα-treated RIE-1 cells only. (B) RIE-1 cells were treated as before and incubated with 
JC-1 dye for 15 min in darkness. The collapse of the electrochemical gradient across the mitochondrial membrane (red fluorescence) was analyzed by 
a FACScan flow cytometer. Mitochondria with intact MMP are represented as green fluorescence. Initiation of MMP decrease is seen at 15 min, and 
recovery at 60 min. (C) RIE-1 cells (1 x 107) were transferred to QO2 chamber and treated with TNFα (10 ng/mL). O2 consumption was significantly 
decreased by ~20% shortly after TNFα treatment (*p < 0.05 vs. control). (D) RIE-1 cells (1 x 104/well) were treated with TNFα and incubated with 
MitoTracker (red fluorescence, mitochondria) and LysoTracker (green fluorescence, lysosomes) dyes. Merged confocal images demonstrated mito-
chondrial autophagy (yellow fluorescence) in damaged RIE-1 cells at 24 h. (E) Cross-section of H&E-stained neonatal mouse intestinal villi demonstrate 
autophagic vacuolization of intestinal epithelial cells in NeC group.www.landesbioscience.com  Oxidative Medicine and Cellular Longevity  301
ROS trapping and ASK1 siRNA attenuate 
TNFα-induced apoptosis and JNK/p38 path-
way activation in RIE-1 cells. To determine 
the  effectiveness  of  mitochondria-targeted 
potential  therapies  during  TNFα/ROS-
induced cell injury, we used ASK1 silencing 
via short interfering RNA (siRNA) treatment 
and spin-trapping compound, α-phenyl-N-t-
butylnitrone (PBN). The dissociation of the 
Trx(SH)2-ASK1 complex, both cytosolic and 
mitochondrial, is a crucial step in activating 
the  JNK-mediated  apoptotic  signaling  cas-
cade.22-26 ASK1 inhibition can be protective 
during TNFα-induced cell injury. Hence, we 
targeted ASK1 with siRNA silencing method 
and  examined  activation  of  JNK  and  p38 
apoptotic pathways, measured by phosphory-
lation levels of proteins following TNFα treat-
ment (Fig. 4A). Protein analysis revealed that 
ASK1 silencing resulted in significant reduc-
tion of JNK and p38 phosphorylation levels 
in TNFα-treated cells. The differential phos-
phorylation of JNK isoforms was observed in 
RIE-1  cells,  indicating  a  complex  isoform-
specific activation process induced by TNFα 
treatment in intestinal epithelial cells. These 
findings  warrant  future  studies  focusing  on 
mitochondrial ASK1 targeting specifically and 
examining JNK isoform-specific activation in 
TNFα-treated intestinal epithelial cells.
Application of spin-trapping of RIE-1 cells 
showed  significant  attenuation  in  TNFα-
induced RIE-1 cell death (Fig. 4B), thus dem-
onstrating a protective effect of ROS-trapping 
by  PBN  in  TNFα/ROS-damaged  intestinal 
epithelial cells. Protein analysis of cell lysates 
revealed significantly attenuated levels of pro-
apoptotic cytochrome c, and marked reduction 
Figure 4. ROS trapping and ASK1 silencing during TNFα-induced activation of apoptotic signaling. (A) ASK1 siRNA- and non-targeted control-trans-
fected RIE-1 cells were treated with TNFα for 15 min and cell lysates were analyzed for phosphorylation of JNK and p38 by western blotting. ASK1 
silencing resulted in significant reduction in the levels of JNK and p38 activation during TNFα treatment. Equal β-actin levels indicate even loading. (B) 
RIE-1 cells (2 x 104/well) were pretreated with PBN for 2 h prior to TNFα treatment. PBN pretreatment dramatically reduced TNFα-induced RIe-1 
cell death (*p < 0.05 vs. control; †p < 0.05 vs. TNFα alone). (C) TNFα-induced activation of JNK/p38 pathway and cytochrome c expression was signifi-
cantly decreased with pBN pretreatment in RIe-1 cells by western blotting.
Figure 3. TNFα activates mitochondrial apoptotic pathways and induces significant intesti-
nal epithelial cell apoptosis. (A) RIE-1 and RIE-1-ρ° cells were treated with TNFα as before. 
apoptosis was measured by DNa fragmentation eLIsa. Data represent triplicate determina-
tions (mean ± SEM; *p < 0.05 vs. control; †p < 0.05 vs. TNFα-treated RIE-1 cells) and experi-
ments were repeated 3 times. TNFα-induced apoptosis was attenuated when compared to 
RIE-1 cells. (B) RIE-1 and RIE-1-ρ° cells (2 x 107) were plated for 24 h, mitochondria isolated 
for protein analysis of mitochondrial apoptotic markers, cytochrome c and APAF-1, by west-
ern blotting. Mitochondrial DNa-damaged RIe-1-ρ° cells showed attenuated mitochondrial 
protein levels. (C) TNFα treatment resulted in increased expression of mitochondrial apop-
totic markers (AIF, APAF-1, cytochrome c and aTp synthase-β) in RIE-1 cells by western blot-
ting. Mitochondrial DNa-damaged RIe-1-ρ° cells treated with TNFα showed unchanged basal 
levels of all apoptotic markers except for increased expression of cytochrome c at 15 min.302  Oxidative Medicine and Cellular Longevity  Volume 2 Issue 5
Mitochondrial dysfunction is found in many disease processes, 
including fulminant hepatic failure in neonates.34,35 Susceptibility 
of premature neonatal intestine to significant oxidant injury dur-
ing NEC as a result of mitochondrial dysfunction has not been 
explored. We have attempted to elucidate some of the early mito-
chondrial functional derangements in RIE-1 cells with TNFα 
treatment,  and  have  shown  that  mitochondrial  integrity  dur-
ing inflammation is compromised, leading to early activation of   
pro-apoptotic  and  mitochondria-dependent  signaling  in  vitro 
(Fig. 5).
It is unclear whether cellular autophagy is a pro-survival or 
pro-apoptotic cellular mechanism. It serves an important pur-
pose in disease processes requiring the maintenance of healthy 
population of mitochondria.36,37 Our findings show that mito-
chondrial damage due to TNFα/ROS elicits late mitochondrial 
autophagy after TNFα exposure in vitro, suggesting either slow 
mitochondrial turnover or delayed mitochondrial biogenesis in 
injured  RIE-1  cells.  These  results  suggest  that  TNFα  affects 
mitochondrial homeostasis and further studies are necessary to 
gain  insight  into  intestinal  mitochondrial  dysfunction  during 
NEC. Our previous findings of oxidative stress-induced intestinal 
cell death and MMP collapse38,39 along with the rapid, transient 
inflammation-induced mtROS production, early mitochondrial 
pro-apoptotic response and ASK1-JNK/p38 stress pathway acti-
vation in intestinal epithelial cells in the current study, suggest a 
strong role for ROS-mediated mechanism(s) of cellular damage 
during NEC.
The selective phosphorylation of JNK isoforms, p56 and p45, 
in response to TNFα suggests that there may be a differential 
pathway of activation of downstream signaling proteins in rat 
intestinal epithelial cells in vitro. For example, although both 
JNK isoforms are phosphorylated during TNFα stimulation, the 
predominantly phosphorylated JNK isoform is p45. In contrast, 
pretreatment with the PBN scavenger specifically decreases p54 
phosphorylation and not phosphorylation of p45 JNK isoform. 
Furthermore, ASK1 silencing with siRNA leads to suppressed 
phosphorylation levels of both JNK isoforms. These findings 
suggest  a  complex  and  possibly  selective  (cytosolic  or  mito-
chondrial only) responses to the TNFα-mediated activation of 
ASK1-JNK/p38 signaling pathways in intestinal epithelial cells 
in vitro.
Regulation of caspase-dependent apoptotic signaling via cyto-
chrome c and APAF-1 release from the mitochondrial matrix 
appears to be a specific response to TNFα treatment as com-
pared to caspase-independent apoptotic signaling. Though both 
apoptotic signaling pathways are activated by TNFα, these find-
ings support our hypothesis that injured mitochondria are a sig-
nificant source of apoptotic signaling in intestinal epithelial cells 
during TNFα/ROS-induced injury, and can lead to potentially 
detrimental compromise of the gut mucosal barrier integrity.
Previous in vivo study by Halpern et al. had already demon-
strated significant attenuation of NEC in neonatal rat, both in 
severity and incidence of intestinal injury, with anti-TNFα treat-
ment. In our study, we examined the in vitro effect of TNFα on 
molecular signaling mechanisms and mitochondrial functional 
changes in intestinal epithelial cells.
in JNK and p38 levels (Fig. 4C). ASK1 inhibition and antioxi-
dant PBN are both effective in protecting RIE-1 cells against 
TNFα/ROS-induced injury.
Discussion
Cytokines are thought to play a central role in gut inflammation 
and injury during NEC by inducing exaggerated inflammatory 
responses, leading to significant intestinal injury in premature 
neonates.3,4 Previous studies have demonstrated that activation 
of inflammatory mediators such as TNFα, IL-1, NFκB, toll-like 
receptors (TLR), IL-8 and inducible NO synthase (iNOS) may 
play a significant role in the pathogenesis of NEC.7,29,30 Recently, 
we  demonstrated  an  anti-inflammatory  action  of  peroxisome 
proliferator-activated receptor (PPAR)γ using in vivo model of 
NEC, and inhibition of NFκB pathway, a critical transcription 
factor for the activation of inflammatory mediators and cytok-
ines.31 De Plaen et al. also have demonstrated that inhibition 
of NFκB pathway during NEC ameliorates bowel injury and 
improves survival in vivo.29 Recent studies have also focused on 
molecular  signaling  mechanism(s)  within  the  TLR  signaling 
pathway32 and cyclooxygenase-2 (COX-2) in intestinal homeo-
stasis  and  inflammation  associated  with  NEC.33  Modulating 
early cellular inflammatory pathways during NEC may improve 
overall survival for neonates.
Previously, we investigated the effects of ROS, generated as 
a result of ischemia-reperfusion injury to the gut, and activation 
of apoptotic and survival signaling during NEC. The aim of the 
present study was to examine the effects of pro-inflammatory 
TNFα on mitochondrial dysfunction in intestinal epithelial cells 
during NEC, since premature neonatal gut is thought to be more 
susceptible  to  inflammatory  cascade  activation  and  oxidative 
injury.
In this study, we observe significant intestinal expression lev-
els of pro-inflammatory TNFα and apoptotic ASK1 molecules 
throughout all layers of the intestine. This indicates that intes-
tinal inflammatory process during NEC is in fact transmural. 
Tissue ASK1 levels also share similar pattern of apoptotic activa-
tion and injury in premature neonatal gut when compared with 
TNFα. One may argue that the human tissue expression levels 
may not fully reflect the exact extent of apoptotic signaling, and 
likely represent a late stage of the disease. Early NEC tissue analy-
sis is a limiting factor in understanding early intestinal responses 
and expression levels of TNFα and ASK1.
Complex relationship between inflammation, oxidative stress 
and activation of apoptotic signaling in intestinal epithelial cells 
may largely depend on early mitochondrial responses during cellu-
lar injury. We demonstrate significant rise in mtROS production, 
alteration of mitochondrial function, activation of ASK1-JNK/
p38 stress signaling and mitochondrial apoptotic cascade in rat 
intestinal epithelial cells with TNFα stimulation. Neonatal tissue 
staining together with our in vitro data demonstrate that inflam-
mation and oxidative stress can induce significant mitochondrial 
deregulation and activation of mitochondria-selective apoptotic 
response, and may possibly lead to intestinal epithelial cell death 
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are the main source of intracellular ROS during TNFα exposure 
in intestinal epithelial cells; and (iii) mitochondria are susceptible 
to TNFα injury; (iv) activation of ASK1-JNK/p38 and mitochon-
drial apoptotic pathways occurs during inflammation-mediated 
ROS injury in intestinal epithelial cells, suggesting a central role 
for mitochondrial dysfunction during TNFα-induced oxidative 
stress. Therapies directed against mitochondria/ROS may pro-
vide important therapeutic options, as well as ameliorate intesti-
nal epithelial cell apoptosis during NEC.
Methods
Human intestinal NEC sections. Paraffin-embedded intestinal 
sections from 20 neonates with NEC and 3 neonates with non-
inflammatory condition of the gastrointestinal (GI) tract (intes-
tinal atresia; control) undergoing bowel resection were analyzed. 
Intestinal tissues were fixed and paraffin-embedded for further 
analysis. Control and NEC sections (5 μm) were prepared for 
immunohistochemical  analysis.  Sections  were  incubated  with 
rabbit  anti-TNFα  (1:200)  and  anti-ASK1  (1:100)  antibodies 
overnight at 4°C, then incubated with an anti-rabbit secondary 
antibody and stained with DAB chromogen (Dako Cytomation 
EnVision® + System-HRP (DAB) kit, Carpinteria, CA). Slides 
were washed, counterstained with hematoxylin, dehydrated and 
Based on our findings, we propose that developing therapies 
specifically directed against mitochondria may be beneficial in 
reducing activation of apoptotic signaling cascades as a result of 
cytokine-mediated oxidative stress in intestinal epithelial cells 
during NEC. Increasing ROS production by the electron trans-
port chain of dysfunctional mitochondria can be attenuated by 
various ROS scavenging compounds. Our successful use of the 
spin-trapping compound, PBN, which protects RIE-1 cells from 
TNFα/ROS-mediated death and attenuates activation of ASK1-
JNK/p38 apoptotic pathway signaling, suggests that ROS scav-
engers may be beneficial.
PBN is widely used for ROS scavenging, and most importantly, 
has been shown to reverse the age-related oxidative changes and 
to reduce oxidative damage from ischemia/reperfusion injury.40-44 
The antioxidant activity of PBN protects biologically important 
molecules from oxidative damage. Although this effect has not 
been demonstrated in NEC intestinal tissues, increasing scientific 
evidence of protective effects of free radical scavengers supports 
their possible use in clinical application, specifically in conditions 
requiring the targeting of diseases of mitochondrial dysfunction.
In conclusion, we have demonstrated that: (i) the pro-inflam-
matory cytokine, TNFα, is abundant in neonatal NEC intesti-
nal sections and can induce significant functional mitochondrial 
deregulation in intestinal epithelial cells in vitro; (ii) mitochondria 
Figure 5. A proposed mechanism of TNFα-induced mitochondrial dysfunction and activation of apoptotic signaling pathways in the intestinal epi-
thelial cells during NEC. Apoptosis-inducing factor (AIF); apoptotic protease activating factor 1 (APAF-1); apoptosis signal-regulating kinase 1 (ASK1); 
c-Jun N-terminal kinase (JNK)/p38 pathway; mitogen-activated protein kinase (MAPK); reactive oxygen species (ROS); thioredoxin-apoptosis signal-
regulating kinase 1 (Trx(SH)2-ASK1) complex; tumor necrosis factor-α (TNFα).304  Oxidative Medicine and Cellular Longevity  Volume 2 Issue 5
ELISAPlus kit (Roche Molecular Biochemicals, Indianapolis, IN) 
according to manufacturer’s instructions.
Western blot analysis. Cell lysates were clarified with cen-
trifugation (13,200 rpm, 20 min at 4°C) and stored at -80°C. 
Protein  concentrations  were  determined  using  the  method 
described by Bradford.45 Equal amounts of total protein (20–30 
μg) were loaded onto NUPAGE 4–12% Bis-Tris Gel and trans-
ferred to PVDF membranes, incubated in a blocking solution for 
1 h (Tris-buffered saline containing 5% nonfat dried milk and 
0.1% Tween 20), incubated with primary antibody overnight 
at 4°C, and then incubated with horseradish peroxidase-con-
jugated secondary antibody. Anti-β-actin antibody (1:5,000), 
total JNK (1:1,000) and p38 (1:1,000) were used for protein 
loading control. All primary antibodies were used in concentra-
tion of 1:1,000 to probe membranes. The immune complexes 
were visualized by ECLPlus (Amersham Biosciences, Piscataway, 
NJ).  Quantitative  densitometric  analyses  of  all  western  blot 
bands (data not shown) were performed using ImageJ (Image 
Processing and Analysis in Java software, National Institutes of 
Health, MD).
ROS  trapping  with  α-phenyl-N-t-butylnitrone  (PBN)  in 
RIE-1 cells. PBN is one of the most widely used spin-trapping 
compounds that target mitochondrial ROS to reverse age-related 
oxidative changes and to alleviate oxidative damage from isch-
emia/reperfusion injury.40-44 RIE-1 (2 x 104) cells were incubated 
with 0.5 mM PBN for 2 h at 37°C. To control for the effects of 
DMSO, a control group of cells were incubated in fresh media 
with DMSO for 2 h. After incubation, cells were treated with 
TNFα (10 ng/mL) for 15 min, and protein was harvested for 
western blot analysis.
ASK1  siRNA  transfection  of  RIE-1  cells.  Rat  SMART 
pool ASK1 and non-targeting control (NTC) siRNA duplexes 
(Dharmacon, Lafayette, CO) were used for transfection by elec-
troporation (400 V/500 μF) in RIE-1 cells. Cells were main-
tained in medium for 48–72 h, then treated with TNFα (10 ng/
mL) for various time points. Extracted protein was analyzed by 
western blotting for phospho-JNK and phospho-p38 expression 
levels.
Dichloro-dihydro-fluorescein (DCFH-DA) flow cytometry 
for ROS generation analysis. Dichlorofluorescein (DCF) fluores-
cence was used to determine intracellular ROS generation based 
on the oxidation of 2',7'-DCFH-DA to a fluorescent 2',7'-DCF. 
RIE-1 and RIE-1-ρ° (1 x 106) cells were treated with TNFα (10 
ng/mL). Cells were trypsinized, washed and incubated with 10 
μM DCFH-DA for 15 min at 37°C. To quantify the intensity 
of DCF fluorescence, the samples were analyzed on a Becton-
Dickenson FACScan flow cytometer (488 nm Argon-ion laser, 
525 ± 10 nm band pass emission filter).
JC-1 assay for detection of MMP changes. To determine 
the effects of TNFα on MMP, we used MitoProbe JC-1 Assay 
kit (Molecular Probes, Eugene, OR). The collapse in the elec-
trochemical gradient across the mitochondrial membrane was 
measured using JC-1 fluorescent cationic dye. RIE-1 cells (1 x 
106) were treated with TNFα (10 ng/mL), washed with PBS and 
incubated with 2 μM JC-1 for 15 min at 37°C in darkness. Cells 
were washed again and analyzed on a FACScan flow cytometer.
cover slipped. For negative control, sections were stained with 
rabbit IgG (not shown).
In vivo murine NEC model. Timed pregnant Swiss-Webster 
mice were purchased (Charles River Labs, Pontage, MI) and 
pup  littermates  were  randomized  to  either  control  or  NEC 
group. All mice in NEC groups were housed in a water bath at 
37°C. They were hand-fed KMR liquid milk replacer formula 
(0.3 cc/g/day; q 3 h) using an animal feeding needle (24 g, ball-
point; Popper & Sons, New Hyde Park, NY). Control mice were 
maternally reared. To induce NEC, pups were stressed twice 
daily with hypoxia by placing them in a plexi-glass chamber, 
breathing 5% oxygen for 10 min. Each mouse was monitored 
daily for the clinical severity of NEC by assessing the level of 
activity, oral intake, weight change and abdominal exam find-
ings.  Mice  that  developed  abdominal  distention,  respiratory 
distress and lethargy during the first 96 h of the experiment 
were sacrificed. After 96 h, all surviving mice were sacrificed 
and distal ileum was harvested for analysis. Segments of ileum 
were fixed in formalin and stored in 70% ethanol for paraffin 
embedding. Intestinal sections were stained with hematoxylin 
and eosin for analysis.
Cell lines and culture techniques. RIE-1 cells (a gift from Dr. 
Kenneth D. Brown; Cambridge Research Station, Cambridge, 
UK) were maintained in Dulbecco’s modified Eagle medium 
(DMEM) supplemented with 5% fetal bovine serum. Cells were 
maintained at 37°C under an atmosphere containing 5% CO2. 
Tissue culture media and reagents were obtained from Invitrogen 
(Carlsbad, CA).
To determine whether mitochondria are the main source of 
TNFα-induced intracellular ROS production, and that activa-
tion of apoptotic pathways is mitochondrial ROS-dependent, we 
established a RIE-1-ρ° from the parent RIE-1 cell line. Silencing 
of mitochondrial function was achieved by maintaining RIE-1 
cells in isolation medium supplemented with 5% fetal bovine 
serum, ethidium bromide, EtBr; 0.1 μg/mL, uridine (50 μg/
mL), pyruvate (100 μg/mL) and glucose (4.5 g/L). To confirm 
successful mtDNA depletion in RIE-1-ρ° cell population, cells 
were evaluated with FACS cell sorting method for EtBr binding 
after 14–16 passages and cell lysates were analyzed for decreased 
mitochondrial cytochrome oxidase subunit 1 protein level using 
western blot analysis (data not shown).
Mitochondrial isolation. To determine the baseline expres-
sion of mitochondrial apoptotic markers in RIE-1 and RIE-1-ρ° 
(2 x 107) cells, mitochondria were isolated using a mitochon-
drial isolation kit according to a manufacturer’s protocol (Pierce, 
Rockford, IL). Mitochondrial lysates were analyzed for mito-
chondrial apoptotic markers (APAF-1, cytochrome c) by western 
blot.
Cell death detection ELISA. RIE-1 and RIE-1-ρ° cells were 
plated onto 24-well plates for 24 h prior to TNFα treatment. Cells 
were incubated with TNFα (10 ng/mL). To determine the effects 
of ROS scavenging on intestinal epithelial cell survival, RIE-1 
cells were first pretreated with α-phenyl-N-t-butylnitrone (PBN; 
0.5 mM) for 2 h, and then incubated with TNFα (10 ng/mL). 
DNA fragmentation was evaluated using a Cell Death Detection www.landesbioscience.com  Oxidative Medicine and Cellular Longevity  305
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